Oxford Cannabinoid Technologies Holdings non-executive chairman and co-founder Neil Mahapatra joined Proactive's Stephen Gunnion to discuss the pharmaceutical company's prospects, and what sets it apart from other cannabis companies that have listed on the market over the past 18 months.
After a successful London IPO, Mahapatra also telling Proactive that listing its shares on the US over-the-counter market is a logical next step and will broaden its shareholder base.